SNUP nasal spray Stada 0.1%, 15 ml

Colorless transparent solution.

Pharmaco-therapeutic group

N4 Acute respiratory diseases with symptoms of rhinitis (runny nose), acute allergic rhinitis, hay fever, sinusitis, eustachitis, otitis media (to reduce swelling of the nasopharyngeal mucosa), to facilitate rhinoscopy and other diagnostic procedures in the nasal passages.

Application during pregnancy and during breastfeeding

During pregnancy, the use of the drug is contraindicated.

During the period of breastfeeding, the drug should be used only after a careful assessment of the risk-benefit ratio for the mother and the infant, it is not allowed to exceed the recommended dosage.

During breastfeeding, you should consult your doctor before using Snoop®.

Dosage form

Nasal spray 0.05% and 0.1%.

15 ml nasal spray (150 doses) in a polyethylene bottle with a spray system.

1 bottle with instructions for medical use of the drug is placed in a cardboard box.

Shelf life

5 years. The contents of the bottle are sterile, without preservatives.

Do not use after the expiration date.

If a medicinal product has expired, do not throw it into wastewater or outside!

Place the medication in the trash can.

These measures will help protect the environment.

Category

Symptomatic drugs

Name ENG

SNUP

Clinical and pharmacological group

A vasoconstrictor drug for topical use in ENT practice.

ATX code

Xylometazoline

Dosage

0.1% x 15ml

Structure

1 ml of nasal spray contains: active ingredient - xylometazoline hydrochloride 0.5 mg or 1.0 mg and auxiliary substances - sea water - 250.0 mg, potassium dihydrogen phosphate - 0.45 mg, purified water - 754.35 mg or 753, 85 mg.

The theoretical total weight is 1005.3 mg.

Indications

Acute respiratory diseases with symptoms of rhinitis (runny nose), acute allergic rhinitis, hay fever, sinusitis, eustachitis, otitis media (to reduce swelling of the nasopharyngeal mucosa), to facilitate rhinoscopy and other diagnostic procedures in the nasal passages.

INN / Active ingredient

xylometazoline

Contraindications

Hypersensitivity to xylometazoline or any other component of the drug

arterial hypertension, tachycardia, severe atherosclerosis

increased intraocular pressure, especially angle-closure glaucoma

atrophic rhinitis, hyperthyroidism, surgical interventions on the meninges (in history), inflammatory diseases of the skin or mucous membrane of the vestibule of the nose, conditions after transsphenoidal hypophysectomy, pregnancy, children under 6 years of age (for 0.1% solution), children up to 2 x years (for 0.05% solution).

Do not use during therapy with monoamine oxidase (MAO) inhibitors (including 14 days after their withdrawal), tricyclic and tetracyclic antidepressants, other local vasoconstrictor agents (decongestants), as well as other drugs that increase blood pressure.

Storage conditions and periods

In a dry, dark place at a temperature not exceeding 25 ° C.

Keep out of the reach of children.

Specifications

Category

Runny nose

Scope of the medicinal product

Ear, Throat, Nose

Release form

Spray

Manufacturer country

Germany

Scope of application

Otorhinolaryngology

Minimum age from

6 years

Way of introduction

Nasally

Vacation conditions

Without recipe

Shelf life after opening

1 year

Volume, ml.

15 ml

Brand name

Stada

The amount of the dosage form in the primary package

15 ml

Primary packaging type

Spray bottle

Type of consumer packaging

Pack of cardboard

Pharmaco-therapeutic group

Decongestant - alpha adrenergic agonist

Anatomical and therapeutic characteristics

R01AA07 Xylometazoline

Dosage form

Nasal spray

Packaging

Cardboard box

Dosage (volume) of the substance in the preparation

xylometazoline hydrochloride 0.5 mg or 1.0 mg

Expiration date in days

1825

The target audience

Adult

Package weight, g

thirty

Mode of application

:

Intranasally.

Snoop® nasal spray 0.05%

For children aged 2 to 6 years, 1 injection into each nostril (if necessary, you can repeat it), up to three times a day.

Adults and children from 6 years of age, 2 sprays in each nostril, up to three times a day.

Snoop® nasal spray 0.1%

Adults and children from 6 years of age, 1 spray in each nostril (if necessary, you can repeat it), up to three times a day.

Snoop® nasal spray 0.1% should not be used in children under 6 years of age.

The drug should not be used more than 3 times a day, the duration of the course is no more than 7 days.

Before use, you must clean the nasal passages.

Remove the protective cap.

Before the first use, press the rim of the spray nozzle several times until a uniform cloud of fog" appears.

The vial with the drug is ready for further use

When using the nozzle, insert it into the nasal cavity and press the rim once.

Keep the bottle upright.

Do not spray horizontally or downward.

It is recommended to inhale slightly through the nose immediately after injection.

After use, close the bottle with a protective cap.

Each bottle must be used individually.

After completion of therapy, the drug can be re-prescribed only after a few days.

The duration of use in children should be consulted with a doctor.

In the case of chronic rhinitis, Snoop® 0.05% and 0.1% can only be used under medical supervision, given the risk of atrophy of the nasal mucosa.

If after treatment there is no improvement or the symptoms worsen, or new symptoms appear, you should consult your doctor.

Use the drug only according to the indications, the method of administration and the doses indicated in the instructions.

Information on technical characteristics, delivery set, country of manufacture "